Skip to main content

Loading market data...

LNTH

Lantheus Holdings, Inc.

NASDAQ • United states

$100.41

+$0.02

(+0.01%)

Source: Yahoo Finance · Quote time Oct 21, 2026 19:47 GMT+0000

Management
Credibility
Score

Lantheus Holdings, Inc. (LNTH)

Unavailable

Quotes may be delayed

$6.55B

Market Cap

1,032,267

Volume

23.8

P/E Ratio

Unavailable

Div Yield

Lantheus Holdings, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

15 Oct 2026

Lantheus Holdings, Inc. reported Shareholder voting results

Lantheus Holdings, Inc. filed an 8-K covering shareholder voting results.

3 Oct 2026

Lantheus Holdings, Inc. proxy and shareholder-vote filing

Lantheus Holdings, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

3 Oct 2026

Lantheus Holdings, Inc. reported Another company event

Lantheus Holdings, Inc. filed an 8-K covering another company event.

24 Sep 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Lantheus Holdings, Inc..

22 Sep 2026

Lantheus Holdings, Inc. proxy and shareholder-vote filing

Lantheus Holdings, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$593.30M

Total assets (USD)$2.41B

Total liabilities (USD)$1.10B

Shareholders' equity (USD)$1.31B

Long-term debt (USD)$557.71M

Debt due within a year (USD)$697,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$388.18M	$100.22M	$75.03M	$1.11	10-Q · 6 Aug 2026
Q1 2026	$377.33M	$81.33M	$118.42M	$1.80	10-Q · 7 May 2026
Q4 2025	$406.79M	$77.18M	$54.09M	Unavailable	10-K · 26 Feb 2026
Q3 2025	$384.01M	$43.62M	$27.77M	$0.41	10-Q · 6 Nov 2025
Q2 2025	$378.05M	$87.97M	$78.76M	$1.12	10-Q · 6 Aug 2025
Q1 2025	$372.76M	$102.07M	$72.95M	$1.02	10-Q · 7 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $104.48

4.1% upside potential

📈

Strong Buy

Unavailable

👍

Buy

0

⏸️

Hold

9

📉

Sell

0

9 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 19:47 UTC Targets range 102.50–109.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

4

Sep 2026

Lantheus Alpha Therapy, LLC

10% owner

Open-market sale

$3.15 per share

167,149 shares

3

Sep 2026

Lantheus Alpha Therapy, LLC

10% owner

Open-market sale

$3.11 per share

80,783 shares

2

Sep 2026

Lantheus Alpha Therapy, LLC

10% owner

Open-market sale

$3.11 per share

42,129 shares

1

Sep 2026

Lantheus Holdings, Inc.

10% owner

Open-market sale

$3.12 per share

35,769 shares

31

Aug 2026

Lantheus Holdings, Inc.

10% owner

Open-market sale

$3.14 per share

78,145 shares

31

Aug 2026

Marshall Robert J. Jr.

CFO and Treasurer

Tax withholding

$100.96 per share

721 shares

17

Aug 2026

Dinkelborg Ludger

See Remarks

Tax withholding

$100.91 per share

2,536 shares

17

Aug 2026

Brown Kimberly

Chief Accounting Officer

Tax withholding

$100.91 per share

463 shares

14

May 2026

Ber Gerard

Director

Tax withholding

$96.67 per share

381 shares

Top Shareholders

Blackrock, Inc.

8,397,642 shares

2.621% change

6/30/2026

Vanguard Group Inc

6,699,381 shares

-3.64% change

12/31/2025

Farallon Capital Management, L.L.C.

5,583,479 shares

0% change

6/30/2026

Jupiter Topco Llc

5,188,416 shares

New% change

6/30/2026

Janus Henderson Group Ltd.

4,774,841 shares

-16.337% change

3/31/2026

Fmr Llc

3,879,971 shares

-16.135% change

6/30/2026

Vanguard Portfolio Management Llc

3,238,471 shares

2.022% change

6/30/2026

Vanguard Capital Management Llc

2,932,214 shares

0.614% change

6/30/2026

American Century Companies Inc

2,816,547 shares

58.135% change

6/30/2026

State Street Corp

2,500,696 shares

2.918% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 19:47 UTC· 11 hours ago

Research coverage and investment tools

Lantheus Holdings, Inc. (LNTH) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). Its last price was US$100.41 on 21 Oct 2026. That is 81% of the way from its 52-week low of US$50.16 to its 52-week high of US$111.86. Its market capitalisation was US$6.55 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$388.18M	$100.22M	$75.03M	$1.11	62.3%	25.8%	—	10-Q · 6 Aug 2026 (opens in a new tab)
Q1 2026	$377.33M	$81.33M	$118.42M	$1.80	61.2%	21.6%	—	10-Q · 7 May 2026 (opens in a new tab)
Q4 2025	$406.79M	$77.18M	$54.09M	Unavailable	59.2%	19.0%	—	10-K · 26 Feb 2026 (opens in a new tab)
Q3 2025	$384.01M	$43.62M	$27.77M	$0.41	57.9%	11.4%	—	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$378.05M	$87.97M	$78.76M	$1.12	63.8%	23.3%	—	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$372.76M	$102.07M	$72.95M	$1.02	63.8%	27.4%	—	10-Q · 7 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/6/2026	$1.32	$1.11	+18.9%
Mar 2026	5/7/2026	$1.21	$1.02	+18.6%
Dec 2025	2/26/2026	$1.46	$0.94	+55.3%
Sep 2025	11/6/2025	$0.99	$1.05	-5.7%

Cash and equivalents: $593.30M
Total assets: $2.41B
Total liabilities: $1.10B
Shareholders' equity: $1.31B
Long-term debt: $557.71M
Debt due within a year: $697,000

8-K · 15 Oct 2026

Lantheus Holdings, Inc. reported Shareholder voting results (opens in a new tab)

Lantheus Holdings, Inc. filed an 8-K covering shareholder voting results.
DEFA14A · 3 Oct 2026

Lantheus Holdings, Inc. proxy and shareholder-vote filing (opens in a new tab)

Lantheus Holdings, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
8-K · 3 Oct 2026

Lantheus Holdings, Inc. reported Another company event (opens in a new tab)

Lantheus Holdings, Inc. filed an 8-K covering another company event.
SCHEDULE 13D/A · 24 Sep 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Lantheus Holdings, Inc..
DEFA14A · 22 Sep 2026

Lantheus Holdings, Inc. proxy and shareholder-vote filing (opens in a new tab)

Lantheus Holdings, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

Insider	Date	Transaction	Shares	Average price	Filing
Lantheus Alpha Therapy, LLC 10% owner	4 Sep 2026	Open-market sale (S)	−167,149	$3.15	Form 4 (opens in a new tab)
Lantheus Alpha Therapy, LLC 10% owner	3 Sep 2026	Open-market sale (S)	−80,783	$3.11	Form 4 (opens in a new tab)
Lantheus Alpha Therapy, LLC 10% owner	2 Sep 2026	Open-market sale (S)	−42,129	$3.11	Form 4 (opens in a new tab)
Lantheus Holdings, Inc. 10% owner	1 Sep 2026	Open-market sale (S)	−35,769	$3.12	Form 4 (opens in a new tab)
Lantheus Holdings, Inc. 10% owner	31 Aug 2026	Open-market sale (S)	−78,145	$3.14	Form 4 (opens in a new tab)
Marshall Robert J. Jr. CFO and Treasurer	31 Aug 2026	Tax withholding (F)	−721	$100.96	Form 4 (opens in a new tab)
Dinkelborg Ludger See Remarks	17 Aug 2026	Tax withholding (F)	−2,536	$100.91	Form 4 (opens in a new tab)
Brown Kimberly Chief Accounting Officer	17 Aug 2026	Tax withholding (F)	−463	$100.91	Form 4 (opens in a new tab)
Ber Gerard Director	14 May 2026	Tax withholding (F)	−381	$96.67	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	8,397,642	2.621%
Vanguard Group Inc	12/31/2025	6,699,381	-3.64%
Farallon Capital Management, L.L.C.	6/30/2026	5,583,479	0%
Jupiter Topco Llc	6/30/2026	5,188,416	New
Janus Henderson Group Ltd.	3/31/2026	4,774,841	-16.337%
Fmr Llc	6/30/2026	3,879,971	-16.135%
Vanguard Portfolio Management Llc	6/30/2026	3,238,471	2.022%
Vanguard Capital Management Llc	6/30/2026	2,932,214	0.614%
American Century Companies Inc	6/30/2026	2,816,547	58.135%
State Street Corp	6/30/2026	2,500,696	2.918%

Previous close: 100.39 USD
Day range: 100.14 – 100.45 USD
52-week range: 50.16 – 111.86 USD
Volume: 1,032,267
Market cap: $6.55B
Average volume: 1,159,686
P/E ratio: 23.8
EPS (FY 2025, diluted): 3.41 USD
Shares outstanding: 65.27M
Beta (5Y monthly): 0.02

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 19:47 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:30 UTC· 42 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for LNTH yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.